Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 21, 2023

Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke

 Really? Please point EXACTLY to the interventions he initiated that got survivors fully recovered. I take no prisoners in advancing stroke recovery and exposing naked emperors. 

What is Dr. Sacco's impact factor in getting survivors recovered?

Renowned neurologist Ralph L. Sacco remembered for leadership, advancements in stroke 

Ralph L. Sacco, MD, MS, professor and chair of the department of neurology at the University of Miami Miller School of Medicine, died on Jan. 17 from glioblastoma, according to a statement from the university.

“Dr. Ralph Sacco’s work helped to cement the Miller School’s reputation and enhance Miami’s world-class standing in stroke and cardiovascular and brain health,” Henri R. Ford, MD, MHA, dean and chief academic officer of the Miller School, said in the statement. “He was a gifted researcher, a committed teacher and mentor, and an irreplaceable friend who was part of the nucleus of our institution.”

A native of New Jersey, Sacco attended Boston University School of Medicine, where he assisted his mentor in the Framingham Heart Study, the country’s longest-running longitudinal analysis of risk for cardiovascular disease. Sacco later joined the faculty at Columbia University, where he founded the Northern Manhattan Stroke Study, an examination of underserved and understudied Black and Latino populations.

picture of male with glasses, white beard
Ralph Sacco

Sacco founded and served as executive director of the Florida Stroke Registry and founding principal investigator of the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities and the Family Study of Stroke Risk and Carotid Atherosclerosis, according to the university statement.

In addition to chairing the department of neurology at the Miller School of Medicine, Sacco was the Olemberg Family Chair in Neurological Disorders, chief of neurology at Jackson Memorial Hospital and executive director of the Evelyn F. McKnight Brain Institute. He also directed and served as multi-principal investigator at the Miami Clinical and Translational Science Institute.

Sacco served as president of the American Academy of Neurology (AAN) from 2017 to 2019 and was the first neurologist to become president of the American Heart Association (AHA), a position he held from 2010 to 2011. Sacco was the only physician to be named head of both professional organizations.

A fellow of the Stroke and Epidemiology Councils of the AHA, the AAN and the American Neurological Association, Sacco also sat on the board of directors of the World Stroke Organization (WSO). He served as editor-in-chief of the AHA’s peer-reviewed scientific journal Stroke.

Sacco received numerous awards and distinctions throughout his career, notably the WSO’s Global Leadership Award and the AHA’s Gold Heart Award, Distinguished National Leadership Award and 2022 Distinguished Scientist Award. At its chair summit in December, the AAN announced the event would be renamed the Ralph L. Sacco Neurology Chair Summit, according to the university statement.

“Ralph was one of a kind,” AHA and American Stroke Association CEO Nancy Brown said in a joint statement from the groups. “His leadership was unparalleled, and his warm, generous heart and care transcended his research and clinic to every person fortunate to meet him and likely become a friend.

“The association is forever grateful that he chose to share his time and extraordinary talents with us, and we will continue to honor his memory through the work we do to champion health equity and brain health resulting in longer, healthier lives for all people.”

Reference:

No comments:

Post a Comment